Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP554877.RApfTzEp-5UkTR3HCijiKQ8UfN-9E0hNy48sQyGixvV08130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP554877.RApfTzEp-5UkTR3HCijiKQ8UfN-9E0hNy48sQyGixvV08130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP554877.RApfTzEp-5UkTR3HCijiKQ8UfN-9E0hNy48sQyGixvV08130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP554877.RApfTzEp-5UkTR3HCijiKQ8UfN-9E0hNy48sQyGixvV08130_provenance.
- NP554877.RApfTzEp-5UkTR3HCijiKQ8UfN-9E0hNy48sQyGixvV08130_assertion description "[The treatment of patients with aggressive lymphomas has improved significantly in recent years, primarily due to the introduction of targeted therapy with the anti-CD20 monoclonal antibody rituximab in combination with chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554877.RApfTzEp-5UkTR3HCijiKQ8UfN-9E0hNy48sQyGixvV08130_provenance.
- NP554877.RApfTzEp-5UkTR3HCijiKQ8UfN-9E0hNy48sQyGixvV08130_assertion evidence source_evidence_literature NP554877.RApfTzEp-5UkTR3HCijiKQ8UfN-9E0hNy48sQyGixvV08130_provenance.
- NP554877.RApfTzEp-5UkTR3HCijiKQ8UfN-9E0hNy48sQyGixvV08130_assertion SIO_000772 16775878 NP554877.RApfTzEp-5UkTR3HCijiKQ8UfN-9E0hNy48sQyGixvV08130_provenance.
- NP554877.RApfTzEp-5UkTR3HCijiKQ8UfN-9E0hNy48sQyGixvV08130_assertion wasDerivedFrom befree-2016 NP554877.RApfTzEp-5UkTR3HCijiKQ8UfN-9E0hNy48sQyGixvV08130_provenance.
- NP554877.RApfTzEp-5UkTR3HCijiKQ8UfN-9E0hNy48sQyGixvV08130_assertion wasGeneratedBy ECO_0000203 NP554877.RApfTzEp-5UkTR3HCijiKQ8UfN-9E0hNy48sQyGixvV08130_provenance.
- befree-2016 importedOn "2016-02-19" NP554877.RApfTzEp-5UkTR3HCijiKQ8UfN-9E0hNy48sQyGixvV08130_provenance.